Qi-Ming Zheng

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Brain Metastases

Small Cell Lung Cancer

Inflammatory Response

Ejection Fraction

Top Venues

Expert review of anticancer therapy

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Qi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, Guo-Xiang Li, Meng-Meng Zhao, Zhi-Gang Sun
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy 23 (6) (2023)
Qi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, Guo-Xiang Li, Meng-Meng Zhao, Zhi-Gang Sun
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy (2023)
Qi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, Guo-Xiang Li, Meng-Meng Zhao, Zhi-Gang Sun
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy (2023)
Rui-Jie Ma, Qi-Ming Zheng, Nan Zhang, Zhi-Gang Sun
Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction. Disease markers 2022 (2022)